Improved Glycaemic Control with IDegLira in Chinese Adults with Type 2 Diabetes in Real-World Settings: A Retrospective, Database Cohort Study

Shanshan Wang; Bei Sun; Dongdong Zhu; Zewei Shen; Xing Zhong; Liming Chen

doi:10.1007/s13300-026-01852-w

March 18, 2026Diabetes TherapyOpen Access

Improved Glycaemic Control with IDegLira in Chinese Adults with Type 2 Diabetes in Real-World Settings: A Retrospective, Database Cohort Study

View Full Paper

Ask AI

Bookmark

Share

Key Points

To evaluate the efficacy of IDegLira for improving glycaemic control in Chinese adults with type 2 diabetes.
Retrospective database cohort study
Evaluated glycaemic parameters such as HbA1c, FPG, and PPG
Analyzed data from a Chinese population with type 2 diabetes
IDegLira significantly reduced HbA1c levels
FPG and PPG levels also showed improvement
Safety profile of IDegLira was favorable

Implication

A retrospective analysis shows improved glycaemic control in adults with type 2 diabetes, suggesting effective treatment benefits.

Abstract

IDegLira statistically improved glycaemic control by reducing HbA1c, FPG, and PPG levels in the Chinese population with T2D, with a favourable safety profile.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/69be37866e48c4981c67737f https://doi.org/10.1007/s13300-026-01852-w

View Full Paper

Ask AI

Bookmark

Share

Improved Glycaemic Control with IDegLira in Chinese Adults with Type 2 Diabetes in Real-World Settings: A Retrospective, Database Cohort Study

Key Points

Implication

Abstract

Discussion

Cite This Study

Improved Glycaemic Control with IDegLira in Chinese Adults with Type 2 Diabetes in Real-World Settings: A Retrospective, Database Cohort Study

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading